MC
Mizuho Capital
Venture CapitalActiveMizuho Capital is a Japanese venture capital firm focused on information technology and biotechnology investments.
293
Investments
5
Exits
$1.5B
AUM
1.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Mizuho Capital.
Investment Thesis & Strategy
Mizuho Capital invests in various stages of information technology and biotechnology companies. They seek to invest in companies with strong growth potential in these sectors.
Investment Activity
Deals per year over the last 8 years
1
20142
20152
20161
20171
20181
20191
20203
2021Portfolio Companies
Selected investments from their portfolio of 293 companies
C
Cellid
Biotech · Series A, 2021
A
Aillis
Healthcare · Series A, 2021
T
TRIPLE-1
Other · Series A, 2021
L
LayerX
Fintech · Series A, 2020
A
Abeja
AI/ML · Series B, 2019
T
TBM
Cleantech · Series C+, 2018
i
iSpace
Other · Series A, 2017
W
WHILL
Robotics · Series B, 2016
S
SmartNews
Media/Content · Series C+, 2016
S
Spiber
Biotech · Series C+, 2015
P
Preferred Networks
AI/ML · Series B, 2015
M
Money Forward
Fintech · Series B, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
SmartNewsAcquisition2023—
SansanIPO2019$800M
ChatworkIPO2019$300M
MercariIPO2018$1.2B
SpeeeIPO2014—
Frequently Asked Questions
Mizuho Capital focuses on Series A, Series B, Series C+ stage investments.